Results 151 to 160 of about 305,673 (272)

Extraction of Soybean and Pea Protein Isolates to Evaluate Therapeutic Potential Against Dexamethasone‐Induced Osteoporosis: In Vivo and in Silico Insights

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
(This graphical abstract demonstrates a comprehensive research study investigating the potential of soybean and pea protein isolates as therapeutic agents for osteoporosis, conducted through both in vivo (animal‐based) and in silico (computational) approaches). ABSTRACT Soybean and pea protein isolates contain essential amino acid that may support bone
Hafiza Humaira Yasmeen   +10 more
wiley   +1 more source

Romosozumab increases bone mineral density in postmenopausal Chinese women with osteoporosis: A randomised phase three study. [PDF]

open access: yesJ Orthop Translat
Zhenlin Z   +18 more
europepmc   +1 more source

Oviductus Ranae as a Functional Food for Ovary Protection: Ameliorating Premature Ovarian Failure and Modulating PI3K/Akt and Apoptosis Pathways in Rats

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
Schematic illustration of the experimental design for evaluating the protective effects of Oviductus Ranae (OR) against cyclophosphamide (CTX)‐induced premature ovarian failure (POF) in rats. Female Wistar rats were intraperitoneally injected with CTX (100 mg/kg on Day 0, followed by 10 mg/kg daily) for 14–16 days to establish the POF model.
Hongyu Zhao   +6 more
wiley   +1 more source

Serum 25-hydroxyvitamin D is associated with islet function in postmenopausal women with type 2 diabetes and osteoporosis. [PDF]

open access: yesFront Endocrinol (Lausanne)
Yin X   +9 more
europepmc   +1 more source

Polyphenolic Components and Phytochemicals Deployed as Nutraceuticals and Pharmafoods

open access: yesFood Science &Nutrition, Volume 14, Issue 7, July 2026.
This review (2010–2025) highlights the therapeutic potential of dietary polyphenols against cancer, diabetes, cardiovascular, neurological, and inflammatory diseases. It summarizes molecular mechanisms, clinical evidence, nanoparticle‐based delivery, bioavailability, safety, toxicity, and future prospects supporting polyphenols as promising therapeutic
Subhash Chandra   +3 more
wiley   +1 more source

Case Report: Gastrointestinal cancer initially presenting as postmenopausal osteoporosis. [PDF]

open access: yesFront Oncol
Li J   +8 more
europepmc   +1 more source

Cellular Senescence and Aging: Mechanisms, Disease Convergence, and Therapeutic Frontiers

open access: yesMedComm, Volume 7, Issue 7, July 2026.
This schematic illustrates the hierarchical and interconnected nature of the primary molecular hallmarks of aging. The progression of aging is driven by a convergence of intrinsic molecular insults. Within the nucleus, genomic instability and telomere attrition trigger persistent DDR, accompanied by extensive epigenetic alterations.
Guowei Cai   +10 more
wiley   +1 more source

A Low Serum Calcium‐to‐Potassium Ratio Predicts Postpartum Venous Thromboembolism Risk: Mediation by Hemoglobin and D‐Dimer in a Multicenter Cohort

open access: yesMedComm, Volume 7, Issue 7, July 2026.
In a large multicenter cohort, a low serum calcium‐to‐potassium (Ca/K) ratio (< 0.55) in the third trimester was a novel risk factor for postpartum venous thromboembolism (VTE). This association was partly explained by concomitant variations in hemoglobin and D‐dimer levels, pointing to integrated management of electrolytes and anemia for postpartum ...
Qian Li   +10 more
wiley   +1 more source

Age, Age‐Related Comorbidities and Survival in Palbociclib, Ribociclib and Abemaciclib Users With Advanced Breast Cancer: A Nation‐Wide Retrospective Cohort Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 7, July 2026.
ABSTRACT Purpose Prevalence of breast cancer (BC) increases with age, but the external validity of data obtained from pivotal trials of medicinal products remains a concern due to the underrepresentation of frail and older adults. Cyclin‐dependent kinase inhibitors (CDKi), palbociclib, abemaciclib, and ribociclib are considered an essential part of the
Blair Rajamaki   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy